Target intelligence / Profile preview

Parkinson disease protein 7 mRNA (PARK7 mRNA) (PARK7 mRNA)

Target
PARK7 mRNA
Molecular classification
Messenger RNA, RNA
01

Overview

The DJ-1/PARK7 mRNA is the transcript of the Parkinson disease protein 7 (PARK7) gene, which encodes the multifunctional protein deglycase DJ-1 [1, 2]. DJ-1 serves as a critical sensor and protector against oxidative stress, functioning as a redox-dependent chaperone and antioxidant that maintains mitochondrial integrity [1, 3]. In neurobiology, loss-of-function mutations in the PARK7 gene are a recognized cause of early-onset autosomal recessive Parkinson's disease, positioning the mRNA as a target for restoration therapies like mRNA replacement or stabilization [3, 5]. Conversely, DJ-1 is frequently overexpressed in various malignancies, where it acts as an oncogene by promoting cell survival, proliferation, and resistance to chemotherapy-induced apoptosis [4]. Consequently, therapeutic strategies targeting the PARK7 mRNA include the use of antisense oligonucleotides (ASOs) or RNA interference (RNAi) to either knockdown its expression in cancer or potentially modulate its levels in neurodegenerative conditions [5]. The dual role of DJ-1 as both a neuroprotective agent and an oncogene presents a significant challenge for therapeutic development, requiring precise control over its expression levels [4, 5].

Other names
DJ-1 mRNAPARK7 transcriptParkinson disease protein 7 mRNAProtein deglycase DJ-1 mRNA
02

Mechanism of action

Antisense inhibition, RNA interference-mediated degradation, and mRNA-based protein restoration [5]

03

Biological functions

Translation template for DJ-1 protein [2]Regulation of oxidative stress response [1]Mitochondrial protection [3]Chaperone activity regulation [1]
04

Disease associations

Parkinson's disease [3]Cancer (e.g., breast, lung, prostate) [4]Ischemic stroke [1]Amyotrophic lateral sclerosis (ALS) [1]
05

Safety considerations

Potential oncogenic risk with DJ-1 overexpression [4]Neurotoxicity risk with excessive DJ-1 knockdown [3]Central nervous system delivery challenges [5]Off-target RNA binding effects
06

Interacting drugs

Experimental antisense oligonucleotides

1 more in the full profile.

07

Biomarkers

DJ-1 protein levels in cerebrospinal fluid (CSF) [PubMed: 21533127]PARK7 mRNA expression levels in tissue [2]Oxidized DJ-1 levels [PubMed: 24503394]

Beyond the preview

Go deeper on Parkinson disease protein 7 mRNA (PARK7 mRNA) (PARK7 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parkinson disease protein 7 mRNA (PARK7 mRNA) (PARK7 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call